In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...

Eti Tsicko's Nandauri, far more psychologically complex than its outline indicates - review Nandauri, named after a Georgian word meaning “The one I long for,” is a dark film that offers a female ...